Clinical Trial Update: Cisplatin (CIS) Administered As Dry Powder for Inhalation (DPI) in Patients with Stage IV Non-Small Cell Lung Cancer [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update outlines a Phase 1/2 study of cisplatin delivered as a dry powder inhalation in patients with Stage IV non-small cell lung cancer, cu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• CISPLATIN (cisplatin)

Snippet

Sponsor: Inhatarget Therapeutics | Conditions: NSCLC (advanced Non-small Cell Lung Cancer), Stage IV Lung Cancer | Phase 1, Phase 2 | Status: RECRUITING